High versus low blood-pressure target in septic shock

New England Journal of Medicine

Volumn 371, Issue 3, 2014, Pages 283-

  Kimmoun, Antoine ^a   Ducrocq, Nicolas ^a   Levy, Bruno ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE AGENT; NORADRENALIN; VASOCONSTRICTOR AGENT;

DRUG COST; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; LACTIC ACIDOSIS; LETTER; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; SEPTIC SHOCK; BLOOD PRESSURE; FEMALE; MALE; METHODOLOGY; NOTE; RESUSCITATION;

BLOOD PRESSURE; FEMALE; HUMANS; MALE; RESUSCITATION; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84904258875     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1406276     Document Type: Letter

References (4)

1. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89.
2. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34:2226-34.
3. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
4. Russell JA. Is there a good MAP for septic shock? N Engl J Med 2014;370:1649-51.